Cargando…
A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China
BACKGROUND: While China is a major manufacturer of artemisinin and its derivatives, it lags as a global leader in terms of the total export value of anti-malarial drugs as finished pharmaceutical products ready for marketing and use by patients. This may be due to the limited number of World Health...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883522/ https://www.ncbi.nlm.nih.gov/pubmed/29615066 http://dx.doi.org/10.1186/s12936-018-2303-8 |